Skip to content
lsd.com
CompletedEarly Phase 1Results posted

EEG Characteristics in ECT

NCT04022226 · University of New Mexico

Closed to entry
Status
Not accepting participants
Early Phase 1
Phase
11
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Number of Participants Assessed for Clinical Efficacy of ECT

    Measured over 1 year

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 65 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Structured Clinical Interview for DSM-5 will confirm diagnosis of MDD or BPD-depressed (with or without psychotic features * The clinical indications for ECT including treatment resistance or a need for a rapid and definitive response; * Hamilton Depression Rating Scale 24-item (HDRS-24) \> 21; and * Age range between 18 and 65 years of age. Exclusion Criteria: * Defined neurological or neurodegenerative disorder (e.g., history of head injury with loss of consciousness \> 5 minutes, epilepsy, Alzheimer's disease); * Other psychiatric conditions (e.g., schizophrenia, schizoaffective disorder, bipolar disorder) * Current drug or alcohol use disorder, except for nicotine and marijuana * Adults unable to consent, pregnant women, prisoner * Non-English speakers * Patients that cannot tolerate Methohexital and Ketamine.

Where

1 study site

FacilityCityRegionCountry
University of New Mexico Mental Health CenterAlbuquerqueNew MexicoUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT04022226 on ClinicalTrials.gov →

Last updated in the registry 2024-10-26. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Recruiting in

All 8 trials from University of New Mexico →